TORONTO — Dr Kieran Moore, Chief Medical Officer of Health, issued the following statement providing an update on the province’s progress responding to this year’s respiratory illness season: “Thanks to the ongoing resilience and commitment of Ontarians, we are seeing a decline in respiratory syncytial virus (RSV), flu and COVID activity throughout the province. RSV trends are beginning to stabilize …
PARIS – Europe and North America are experiencing shortages of several antibiotics and other medications as illnesses have increased. Doctors and the hospitals, alike in North America are under pressure due to surge in illnesses – a combination of COVID-19, influenza and the respiratory syncytial virus (RSV) that is the cause of bronchiolitis.
Ottawa – The respiratory syncytial virus (RSV) are rising in Canada, particularly in children. It causes infections in respiratory tract. Doctors say as cases are increasing in the United States, it is affecting Canada too. The Public Health Agency of Canada, in its latest respiratory virus detection report has mentioned rise in positive RSV cases since early September adding cases …
London – US drugmaker Moderna says it is working on a single Covid vaccine that would work against both Covid and flu and will be ready by 2023. It hopes to create a jab that tackles Covid, influenza and respiratory syncytial virus (RSV), by the winter of 2024, a company report says.
